BibTex RIS Kaynak Göster

Prebiyotik ve Probiyotikler

Yıl 2004, Cilt: 2 Sayı: 4, 142 - 145, 01.12.2004

Öz

Gastrointestinal sistem G‹S doğum sırasında steril iken saatler içerisinde mikroorganizmalar ile kolonize olur. GİS’in kolonizasyonu, çeşitli etmenlerin dinamik bir etkileşimiyle oluşan karmaşık bir olaydır. İntestinal flora yaklaşık 1012 hücre/gm kuru ağırlık oranında ve 400-500 türden bakteri içermektedir 1,2 . Bunun total vücut hücrelerinin yaklaşık %95’ini oluşturduğu göz önüne alınırsa kalın bağırsakların oldukça özelleşmiş ve aktif bir organ olduğu anlaşılmaktadır.

Kaynakça

  • 1. Mountzouris KC, Gibson GR. Colonization of gastrointestinal tract. An￾nales Nestle 2003;61:43-54.
  • 2. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroen￾terology 1984;86:74-93.
  • 3. Chapman MH, Sanderson IR. Intestinal flora and mucosal immune sys￾tem. Annales Nestle 2003;61:55-65.
  • 4. Bengmark S. Pre-, pro and synbiotics. Curr Opin Clin Nutr Metab Care 2001;4:571-79.
  • 5. Guarner F, Malagelda JR. Gut flora in health and disease. Lancet 2003;22:360-6.
  • 6. Gibson GR. Prebiotics. Best Pract Res Clin Gastroenterol 2004;18:287- 98.
  • 7. Gibson GR, Roberfroid MB. Dietary modulasyon of human colonic mic￾robiota: Introducing the concept of prebiotics. J Nutr 1995;125:1401-12.
  • 8. Schrezenmeir J, de Vrese M. Probiotics, prebiotics and synbiotics-app￾roaching a definition. Am J Clin Nutr 2001;73(suppl):361–4.
  • 9. Dugas B, Mercenier A, Lenoir-Winjkoop I, et al. Immunity and probi￾otics. Immunol Today 1999;20:387-90.
  • 10. Gill HS. Probiotics to enhance anti-infective defence in the gastrointes￾tinal tract. Best Pract Res Clin Gastroenterol 2003;17:755-73.
  • 11. Schiffrin EJ, Rochat F, Link-Amster HA et al. Immune system stimulati￾on by probiotics. J Dairy Science 1995; 78: 1597–1606.
  • 12. Young RJ, Huffman S. Probiotic use in children. J Pediatr Health Care 2003;17:277-83.
  • 13. Isolauri E. The role of probiotics in paediatrics. Current Paediatrics 2004;14:104–9.
  • 14. Sanders ME. Probiotics:consideration for human health. Nutr Rev 2003;61:91-9.
  • 15. Isolauri E. Probiotics in human disease. Am J Clin Nutr 2001;73:1142S–6S.
  • 16. Szajewska H, Kotowska M, Mrukowich JZ, et al. Efficacy of Lactobacil￾lus GG in prevention of rotavirus nosocomial infection J Pediatr 2001:138:361-5.
  • 17. Isolauri E. Probiotics for infectious diarrhoea. Gut 2003;52:436–7.
  • 18. Isolauri E, Kirjavainen PV, Salminen S. Probiotics role in the treatment of intestinal infection and inflammation? Gut 2002;50(suppl IIP):54–9.
  • 19. Szajewska H, Mrukowich JZ. Probiotics in the teatment and prevention of acute infectious diarrhea in infants and children: a systematic revi￾ew of published randomized, double-blind, placebo controlled trial. J Pediatr Gastroenterol Nutr 2001;33:17-25.
  • 20. Fukushima Y, Kawata Y, Hara H, et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998;42:39-44.
  • 21. Cross ML. Immunoregulation by probitic lactobacilli: pro-Th1 signals and their relevance to human health. Clin Appl Immunol Reviews 2002;34 (suppl 21):S37-43.
  • 22. Varla O. Immunological effects of probiotics with special referrence to lactobacilli. Clin Exp Allergy 2003;33:1634-40.
  • 23. Salminen S, Matilla-Sandholm T. Screening effective probiotic strains. Biosci Microflora 1996;15:61-7.
  • 24. Cross ML, Ganner A, Teilab D, Fray LM. Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immu￾nology and Medical Microbiology 2004;42: 173–80.
  • 25. von derWeid T, Bulliard C & Schiffrin EJ. Induction by a lactic acid bac￾terium of a population of CD4 T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin Diag Lab Immunol 2001; 8: 695–701.
  • 26. Bjorksten B, Naaber P, Sepp E, et al. The intestinal microflora in aller￾gic Estonian and Swedish 2-year old children. Clin Exp Allergy 1999;29:342-6.
  • 27. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allrgy. J Allergy Clin Immunol 1997;99:179-85.
  • 28. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary pre￾vention of atopic disease: a randomised placebo-controlled trial. Lan￾cet 2001;357:1076-9.
  • 29. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow of a randomised placebo-controlled trial. Lancet 2003;361:1869-71.
  • 30. Isolauri, E., Joensuu, J., Suomalainen, H., Luomala, M., & Vesikari, T. Improved immunogenicity of oral D x RRV reassortant rotavirus vacci￾ne by Lactobacillus casei GG. Vaccine 1995; 13, 310-2.
  • 31. Tromboli CP, Caucheteus C, Cortot A, et al. Probiotics in inflammatory bowel disease: a critical review. Best Pract Res Clin Gastroenterol 2003;17:805-20
  • 32. Gionchetti P, Rizzello F, Campieri M. Probiotics and antibiotics in inf￾lammatory bowel disease. Curr Opinion Gastroenterol 2001;17:331-5
  • 33. Malin M, Verronen P, Korhonen A, et al. Dietary therapy with Lactoba￾cillus GG, bovine colostrum in patients with juvenile chronic arthritis: evaluation of effect on gut defence mechanisms. Inflammaphar￾macology 1997;5.219-36.
Yıl 2004, Cilt: 2 Sayı: 4, 142 - 145, 01.12.2004

Öz

Kaynakça

  • 1. Mountzouris KC, Gibson GR. Colonization of gastrointestinal tract. An￾nales Nestle 2003;61:43-54.
  • 2. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroen￾terology 1984;86:74-93.
  • 3. Chapman MH, Sanderson IR. Intestinal flora and mucosal immune sys￾tem. Annales Nestle 2003;61:55-65.
  • 4. Bengmark S. Pre-, pro and synbiotics. Curr Opin Clin Nutr Metab Care 2001;4:571-79.
  • 5. Guarner F, Malagelda JR. Gut flora in health and disease. Lancet 2003;22:360-6.
  • 6. Gibson GR. Prebiotics. Best Pract Res Clin Gastroenterol 2004;18:287- 98.
  • 7. Gibson GR, Roberfroid MB. Dietary modulasyon of human colonic mic￾robiota: Introducing the concept of prebiotics. J Nutr 1995;125:1401-12.
  • 8. Schrezenmeir J, de Vrese M. Probiotics, prebiotics and synbiotics-app￾roaching a definition. Am J Clin Nutr 2001;73(suppl):361–4.
  • 9. Dugas B, Mercenier A, Lenoir-Winjkoop I, et al. Immunity and probi￾otics. Immunol Today 1999;20:387-90.
  • 10. Gill HS. Probiotics to enhance anti-infective defence in the gastrointes￾tinal tract. Best Pract Res Clin Gastroenterol 2003;17:755-73.
  • 11. Schiffrin EJ, Rochat F, Link-Amster HA et al. Immune system stimulati￾on by probiotics. J Dairy Science 1995; 78: 1597–1606.
  • 12. Young RJ, Huffman S. Probiotic use in children. J Pediatr Health Care 2003;17:277-83.
  • 13. Isolauri E. The role of probiotics in paediatrics. Current Paediatrics 2004;14:104–9.
  • 14. Sanders ME. Probiotics:consideration for human health. Nutr Rev 2003;61:91-9.
  • 15. Isolauri E. Probiotics in human disease. Am J Clin Nutr 2001;73:1142S–6S.
  • 16. Szajewska H, Kotowska M, Mrukowich JZ, et al. Efficacy of Lactobacil￾lus GG in prevention of rotavirus nosocomial infection J Pediatr 2001:138:361-5.
  • 17. Isolauri E. Probiotics for infectious diarrhoea. Gut 2003;52:436–7.
  • 18. Isolauri E, Kirjavainen PV, Salminen S. Probiotics role in the treatment of intestinal infection and inflammation? Gut 2002;50(suppl IIP):54–9.
  • 19. Szajewska H, Mrukowich JZ. Probiotics in the teatment and prevention of acute infectious diarrhea in infants and children: a systematic revi￾ew of published randomized, double-blind, placebo controlled trial. J Pediatr Gastroenterol Nutr 2001;33:17-25.
  • 20. Fukushima Y, Kawata Y, Hara H, et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998;42:39-44.
  • 21. Cross ML. Immunoregulation by probitic lactobacilli: pro-Th1 signals and their relevance to human health. Clin Appl Immunol Reviews 2002;34 (suppl 21):S37-43.
  • 22. Varla O. Immunological effects of probiotics with special referrence to lactobacilli. Clin Exp Allergy 2003;33:1634-40.
  • 23. Salminen S, Matilla-Sandholm T. Screening effective probiotic strains. Biosci Microflora 1996;15:61-7.
  • 24. Cross ML, Ganner A, Teilab D, Fray LM. Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immu￾nology and Medical Microbiology 2004;42: 173–80.
  • 25. von derWeid T, Bulliard C & Schiffrin EJ. Induction by a lactic acid bac￾terium of a population of CD4 T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin Diag Lab Immunol 2001; 8: 695–701.
  • 26. Bjorksten B, Naaber P, Sepp E, et al. The intestinal microflora in aller￾gic Estonian and Swedish 2-year old children. Clin Exp Allergy 1999;29:342-6.
  • 27. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allrgy. J Allergy Clin Immunol 1997;99:179-85.
  • 28. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary pre￾vention of atopic disease: a randomised placebo-controlled trial. Lan￾cet 2001;357:1076-9.
  • 29. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow of a randomised placebo-controlled trial. Lancet 2003;361:1869-71.
  • 30. Isolauri, E., Joensuu, J., Suomalainen, H., Luomala, M., & Vesikari, T. Improved immunogenicity of oral D x RRV reassortant rotavirus vacci￾ne by Lactobacillus casei GG. Vaccine 1995; 13, 310-2.
  • 31. Tromboli CP, Caucheteus C, Cortot A, et al. Probiotics in inflammatory bowel disease: a critical review. Best Pract Res Clin Gastroenterol 2003;17:805-20
  • 32. Gionchetti P, Rizzello F, Campieri M. Probiotics and antibiotics in inf￾lammatory bowel disease. Curr Opinion Gastroenterol 2001;17:331-5
  • 33. Malin M, Verronen P, Korhonen A, et al. Dietary therapy with Lactoba￾cillus GG, bovine colostrum in patients with juvenile chronic arthritis: evaluation of effect on gut defence mechanisms. Inflammaphar￾macology 1997;5.219-36.
Toplam 33 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Collection
Yazarlar

Mustafa Yılmaz Bu kişi benim

Yayımlanma Tarihi 1 Aralık 2004
Yayımlandığı Sayı Yıl 2004 Cilt: 2 Sayı: 4

Kaynak Göster

APA Yılmaz, M. (2004). Prebiyotik ve Probiyotikler. Güncel Pediatri, 2(4), 142-145.
AMA Yılmaz M. Prebiyotik ve Probiyotikler. Güncel Pediatri. Aralık 2004;2(4):142-145.
Chicago Yılmaz, Mustafa. “Prebiyotik Ve Probiyotikler”. Güncel Pediatri 2, sy. 4 (Aralık 2004): 142-45.
EndNote Yılmaz M (01 Aralık 2004) Prebiyotik ve Probiyotikler. Güncel Pediatri 2 4 142–145.
IEEE M. Yılmaz, “Prebiyotik ve Probiyotikler”, Güncel Pediatri, c. 2, sy. 4, ss. 142–145, 2004.
ISNAD Yılmaz, Mustafa. “Prebiyotik Ve Probiyotikler”. Güncel Pediatri 2/4 (Aralık 2004), 142-145.
JAMA Yılmaz M. Prebiyotik ve Probiyotikler. Güncel Pediatri. 2004;2:142–145.
MLA Yılmaz, Mustafa. “Prebiyotik Ve Probiyotikler”. Güncel Pediatri, c. 2, sy. 4, 2004, ss. 142-5.
Vancouver Yılmaz M. Prebiyotik ve Probiyotikler. Güncel Pediatri. 2004;2(4):142-5.